Report Thumbnail
Product Code LP091401147487P
Published Date 2023/3/15
LP Information
English109 PagesGlobal

Global Travel Vaccines Market Growth 2023-2029 ‐ Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code LP091401147487P◆The Mar 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2023/3/15
LP Information
English 109 PagesGlobal

Global Travel Vaccines Market Growth 2023-2029 ‐ Pharmaceutical_LifeSciense Market


Abstract

Summary

Exposure to new environments and diseases can put travellers at an increased risk of serious illness. Travel vaccines against diseases such as hepatitis A and B, rabies, typhoid and cholera
LPI (LP Information)' newest research report, the “Travel Vaccines Industry Forecast” looks at past sales and reviews total world Travel Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Travel Vaccines sales for 2023 through 2029. With Travel Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Travel Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Travel Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Travel Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Travel Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Travel Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Travel Vaccines.
The global Travel Vaccines market size is projected to grow from US$ 5350.1 million in 2022 to US$ 9273.4 million in 2029; it is expected to grow at a CAGR of 9273.4 from 2023 to 2029.
United States market for Travel Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Travel Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Travel Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Travel Vaccines players cover GSK, Sanofi, Merck, Pfizer, Jintan, CSL, MedImmune LLC, J&J(Crucell) and China National Biotec, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Travel Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Cholera
Rabies Vaccine
Hepatitis
Typhoid
Segmentation by application
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GSK
Sanofi
Merck
Pfizer
Jintan
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Key Questions Addressed in this Report
What is the 10-year outlook for the global Travel Vaccines market?
What factors are driving Travel Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Travel Vaccines market opportunities vary by end market size?
How does Travel Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats

  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Travel Vaccines Annual Sales 2018-2029
      • 2.1.2 World Current & Future Analysis for Travel Vaccines by Geographic Region, 2018, 2022 & 2029
      • 2.1.3 World Current & Future Analysis for Travel Vaccines by Country/Region, 2018, 2022 & 2029
    • 2.2 Travel Vaccines Segment by Type
      • 2.2.1 Cholera
      • 2.2.2 Rabies Vaccine
      • 2.2.3 Hepatitis
      • 2.2.4 Typhoid
    • 2.3 Travel Vaccines Sales by Type
      • 2.3.1 Global Travel Vaccines Sales Market Share by Type (2018-2023)
      • 2.3.2 Global Travel Vaccines Revenue and Market Share by Type (2018-2023)
      • 2.3.3 Global Travel Vaccines Sale Price by Type (2018-2023)
    • 2.4 Travel Vaccines Segment by Application
      • 2.4.1 Hospital
      • 2.4.2 Clinic
    • 2.5 Travel Vaccines Sales by Application
      • 2.5.1 Global Travel Vaccines Sale Market Share by Application (2018-2023)
      • 2.5.2 Global Travel Vaccines Revenue and Market Share by Application (2018-2023)
      • 2.5.3 Global Travel Vaccines Sale Price by Application (2018-2023)

  • 3 Global Travel Vaccines by Company

    • 3.1 Global Travel Vaccines Breakdown Data by Company
      • 3.1.1 Global Travel Vaccines Annual Sales by Company (2018-2023)
      • 3.1.2 Global Travel Vaccines Sales Market Share by Company (2018-2023)
    • 3.2 Global Travel Vaccines Annual Revenue by Company (2018-2023)
      • 3.2.1 Global Travel Vaccines Revenue by Company (2018-2023)
      • 3.2.2 Global Travel Vaccines Revenue Market Share by Company (2018-2023)
    • 3.3 Global Travel Vaccines Sale Price by Company
    • 3.4 Key Manufacturers Travel Vaccines Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Travel Vaccines Product Location Distribution
      • 3.4.2 Players Travel Vaccines Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    • 3.6 New Products and Potential Entrants
    • 3.7 Mergers & Acquisitions, Expansion

  • 4 World Historic Review for Travel Vaccines by Geographic Region

    • 4.1 World Historic Travel Vaccines Market Size by Geographic Region (2018-2023)
      • 4.1.1 Global Travel Vaccines Annual Sales by Geographic Region (2018-2023)
      • 4.1.2 Global Travel Vaccines Annual Revenue by Geographic Region (2018-2023)
    • 4.2 World Historic Travel Vaccines Market Size by Country/Region (2018-2023)
      • 4.2.1 Global Travel Vaccines Annual Sales by Country/Region (2018-2023)
      • 4.2.2 Global Travel Vaccines Annual Revenue by Country/Region (2018-2023)
    • 4.3 Americas Travel Vaccines Sales Growth
    • 4.4 APAC Travel Vaccines Sales Growth
    • 4.5 Europe Travel Vaccines Sales Growth
    • 4.6 Middle East & Africa Travel Vaccines Sales Growth

  • 5 Americas

    • 5.1 Americas Travel Vaccines Sales by Country
      • 5.1.1 Americas Travel Vaccines Sales by Country (2018-2023)
      • 5.1.2 Americas Travel Vaccines Revenue by Country (2018-2023)
    • 5.2 Americas Travel Vaccines Sales by Type
    • 5.3 Americas Travel Vaccines Sales by Application
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil

  • 6 APAC

    • 6.1 APAC Travel Vaccines Sales by Region
      • 6.1.1 APAC Travel Vaccines Sales by Region (2018-2023)
      • 6.1.2 APAC Travel Vaccines Revenue by Region (2018-2023)
    • 6.2 APAC Travel Vaccines Sales by Type
    • 6.3 APAC Travel Vaccines Sales by Application
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan

  • 7 Europe

    • 7.1 Europe Travel Vaccines by Country
      • 7.1.1 Europe Travel Vaccines Sales by Country (2018-2023)
      • 7.1.2 Europe Travel Vaccines Revenue by Country (2018-2023)
    • 7.2 Europe Travel Vaccines Sales by Type
    • 7.3 Europe Travel Vaccines Sales by Application
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia

  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Travel Vaccines by Country
      • 8.1.1 Middle East & Africa Travel Vaccines Sales by Country (2018-2023)
      • 8.1.2 Middle East & Africa Travel Vaccines Revenue by Country (2018-2023)
    • 8.2 Middle East & Africa Travel Vaccines Sales by Type
    • 8.3 Middle East & Africa Travel Vaccines Sales by Application
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries

  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends

  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Travel Vaccines
    • 10.3 Manufacturing Process Analysis of Travel Vaccines
    • 10.4 Industry Chain Structure of Travel Vaccines

  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Travel Vaccines Distributors
    • 11.3 Travel Vaccines Customer

  • 12 World Forecast Review for Travel Vaccines by Geographic Region

    • 12.1 Global Travel Vaccines Market Size Forecast by Region
      • 12.1.1 Global Travel Vaccines Forecast by Region (2024-2029)
      • 12.1.2 Global Travel Vaccines Annual Revenue Forecast by Region (2024-2029)
    • 12.2 Americas Forecast by Country
    • 12.3 APAC Forecast by Region
    • 12.4 Europe Forecast by Country
    • 12.5 Middle East & Africa Forecast by Country
    • 12.6 Global Travel Vaccines Forecast by Type
    • 12.7 Global Travel Vaccines Forecast by Application

  • 13 Key Players Analysis

    • 13.1 GSK
      • 13.1.1 GSK Company Information
      • 13.1.2 GSK Travel Vaccines Product Portfolios and Specifications
      • 13.1.3 GSK Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.1.4 GSK Main Business Overview
      • 13.1.5 GSK Latest Developments
    • 13.2 Sanofi
      • 13.2.1 Sanofi Company Information
      • 13.2.2 Sanofi Travel Vaccines Product Portfolios and Specifications
      • 13.2.3 Sanofi Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.2.4 Sanofi Main Business Overview
      • 13.2.5 Sanofi Latest Developments
    • 13.3 Merck
      • 13.3.1 Merck Company Information
      • 13.3.2 Merck Travel Vaccines Product Portfolios and Specifications
      • 13.3.3 Merck Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.3.4 Merck Main Business Overview
      • 13.3.5 Merck Latest Developments
    • 13.4 Pfizer
      • 13.4.1 Pfizer Company Information
      • 13.4.2 Pfizer Travel Vaccines Product Portfolios and Specifications
      • 13.4.3 Pfizer Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.4.4 Pfizer Main Business Overview
      • 13.4.5 Pfizer Latest Developments
    • 13.5 Jintan
      • 13.5.1 Jintan Company Information
      • 13.5.2 Jintan Travel Vaccines Product Portfolios and Specifications
      • 13.5.3 Jintan Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.5.4 Jintan Main Business Overview
      • 13.5.5 Jintan Latest Developments
    • 13.6 CSL
      • 13.6.1 CSL Company Information
      • 13.6.2 CSL Travel Vaccines Product Portfolios and Specifications
      • 13.6.3 CSL Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.6.4 CSL Main Business Overview
      • 13.6.5 CSL Latest Developments
    • 13.7 MedImmune LLC
      • 13.7.1 MedImmune LLC Company Information
      • 13.7.2 MedImmune LLC Travel Vaccines Product Portfolios and Specifications
      • 13.7.3 MedImmune LLC Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.7.4 MedImmune LLC Main Business Overview
      • 13.7.5 MedImmune LLC Latest Developments
    • 13.8 J&J(Crucell)
      • 13.8.1 J&J(Crucell) Company Information
      • 13.8.2 J&J(Crucell) Travel Vaccines Product Portfolios and Specifications
      • 13.8.3 J&J(Crucell) Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.8.4 J&J(Crucell) Main Business Overview
      • 13.8.5 J&J(Crucell) Latest Developments
    • 13.9 China National Biotec
      • 13.9.1 China National Biotec Company Information
      • 13.9.2 China National Biotec Travel Vaccines Product Portfolios and Specifications
      • 13.9.3 China National Biotec Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.9.4 China National Biotec Main Business Overview
      • 13.9.5 China National Biotec Latest Developments
    • 13.10 Tiantan
      • 13.10.1 Tiantan Company Information
      • 13.10.2 Tiantan Travel Vaccines Product Portfolios and Specifications
      • 13.10.3 Tiantan Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.10.4 Tiantan Main Business Overview
      • 13.10.5 Tiantan Latest Developments
    • 13.11 Hualan
      • 13.11.1 Hualan Company Information
      • 13.11.2 Hualan Travel Vaccines Product Portfolios and Specifications
      • 13.11.3 Hualan Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.11.4 Hualan Main Business Overview
      • 13.11.5 Hualan Latest Developments
    • 13.12 Kangtai
      • 13.12.1 Kangtai Company Information
      • 13.12.2 Kangtai Travel Vaccines Product Portfolios and Specifications
      • 13.12.3 Kangtai Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.12.4 Kangtai Main Business Overview
      • 13.12.5 Kangtai Latest Developments
    • 13.13 Hissen
      • 13.13.1 Hissen Company Information
      • 13.13.2 Hissen Travel Vaccines Product Portfolios and Specifications
      • 13.13.3 Hissen Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.13.4 Hissen Main Business Overview
      • 13.13.5 Hissen Latest Developments

  • 14 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.